Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 5 studies | 43% ± 13% | |
| GABAergic neuron | 3 studies | 40% ± 3% | |
| interneuron | 3 studies | 41% ± 21% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 38% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 96% | 3618.26 | 2544 / 2642 | 93% | 11.33 | 655 / 705 |
| adrenal gland | 76% | 826.58 | 195 / 258 | 96% | 47.93 | 221 / 230 |
| breast | 45% | 452.30 | 208 / 459 | 89% | 17.67 | 994 / 1118 |
| intestine | 46% | 552.18 | 448 / 966 | 46% | 3.39 | 243 / 527 |
| spleen | 90% | 805.11 | 216 / 241 | 0% | 0 | 0 / 0 |
| pancreas | 51% | 272.95 | 168 / 328 | 38% | 6.37 | 68 / 178 |
| esophagus | 34% | 459.98 | 497 / 1445 | 53% | 6.91 | 97 / 183 |
| skin | 61% | 1324.81 | 1099 / 1809 | 7% | 0.39 | 32 / 472 |
| ovary | 1% | 4.63 | 2 / 180 | 63% | 3.48 | 271 / 430 |
| lung | 1% | 4.36 | 4 / 578 | 52% | 4.70 | 598 / 1155 |
| tonsil | 0% | 0 | 0 / 0 | 49% | 4.76 | 22 / 45 |
| uterus | 2% | 22.31 | 3 / 170 | 40% | 3.01 | 184 / 459 |
| stomach | 6% | 27.18 | 20 / 359 | 34% | 2.87 | 98 / 286 |
| thymus | 13% | 56.56 | 85 / 653 | 20% | 0.92 | 124 / 605 |
| bladder | 0% | 0 | 0 / 21 | 24% | 1.71 | 123 / 504 |
| peripheral blood | 20% | 117.32 | 186 / 929 | 0% | 0 | 0 / 0 |
| prostate | 0% | 0 | 0 / 245 | 15% | 0.67 | 73 / 502 |
| lymph node | 0% | 0 | 0 / 0 | 14% | 0.32 | 4 / 29 |
| kidney | 0% | 0 | 0 / 89 | 7% | 0.38 | 66 / 901 |
| eye | 0% | 0 | 0 / 0 | 6% | 0.27 | 5 / 80 |
| heart | 5% | 27.34 | 43 / 861 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 5% | 0.33 | 20 / 406 |
| adipose | 0% | 2.69 | 5 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0.52 | 1 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0.43 | 1 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006812 | Biological process | monoatomic cation transport |
| GO_0098655 | Biological process | monoatomic cation transmembrane transport |
| GO_0003094 | Biological process | glomerular filtration |
| GO_0005886 | Cellular component | plasma membrane |
| GO_1990760 | Molecular function | osmolarity-sensing monoatomic cation channel activity |
| GO_0005227 | Molecular function | calcium-activated cation channel activity |
| Gene name | TMEM63C |
| Protein name | Calcium permeable stress-gated cation channel 1 (Transmembrane protein 63C) Transmembrane protein 63C |
| Synonyms | C14orf171 CSC1 |
| Description | FUNCTION: Acts as an osmosensitive calcium-permeable cation channel . Required for the functional integrity of the kidney glomerular filtration barrier (By similarity). . |
| Accessions | ENST00000557408.5 ENST00000298351.5 Q9P1W3 G3V3S9 G3V2V1 G3V4J5 ENST00000555338.5 G3V3S4 ENST00000556514.5 ENST00000554766.5 ENST00000554346.5 G3V3H0 |